Insulet (PODD) Share-based Compensation Growth (3y) (2013 - 2026)
Powered by 
Analysis
Insulet (PODD) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 8.37% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | -22.92% |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 19.64% |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | -28.31% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 0.55% |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 4.11% |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 7.30% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | -0.59% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 3.40% |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 14.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.37% |
| Mar 31, 2026 | 20.74% |
| Dec 31, 2025 | 21.92% |
| Sep 30, 2025 | 22.88% |
| Jun 30, 2025 | -5.90% |
| Mar 31, 2025 | 11.48% |
| Dec 31, 2024 | 43.28% |
| Sep 30, 2024 | 292.21% |
| Jun 30, 2024 | 141.97% |
| Mar 31, 2024 | -18.36% |
| Dec 31, 2023 | 12.16% |
| Sep 30, 2023 | 371.77% |
| Jun 30, 2023 | 101.55% |
| Mar 31, 2023 | -21.69% |
| Dec 31, 2022 | 11.87% |
| Sep 30, 2022 | 10.89% |
| Jun 30, 2022 | -6.47% |
| Mar 31, 2022 | 26.83% |
| Dec 31, 2021 | 2.61% |
| Sep 30, 2021 | -73.48% |